Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew F Russo

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Cephalalgia : an International Journal of Headache|April 9, 2014
Migraine meets membrane traffickingAndrew F Russo
Headache|May 10, 2017
Overview of Neuropeptides: Awakening the Senses?Andrew F Russo
Pharmacogenomics|February 5, 2008
Ramping it up: RAMP1 and the implications for migraineAndrew F Russo
Annual Review of Pharmacology and Toxicology|October 24, 2014
Calcitonin gene-related peptide (CGRP): a new target for migraineAndrew F Russo
ACS Pharmacology & Translational Science|September 28, 2019
CGRP-based Migraine Therapeutics: How Might They Work, Why So Safe, and What Next?Andrew F Russo
British Journal of Clinical Pharmacology|June 3, 2015
CGRP as a neuropeptide in migraine: lessons from miceAndrew F Russo
Current Opinion in Neurology|May 13, 2009
Calcitonin gene-related peptide: an update on the biologyAna Recober, Andrew F Russo
The Journal of Headache and Pain|April 3, 2023
Shared and independent roles of CGRP and PACAP in migraine pathophysiologyAdisa Kuburas, Andrew F Russo
Idrugs : the Investigational Drugs Journal|August 1, 2007
Olcegepant, a non-peptide CGRP1 antagonist for migraine treatmentAna Recober, Andrew F Russo
Cephalalgia : an International Journal of Headache|July 11, 2018
Current understanding of trigeminal ganglion structure and function in headacheKarl Messlinger, Andrew F Russo
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Cephalalgia : an International Journal of Headache|April 9, 2014
Migraine meets membrane traffickingAndrew F Russo
Headache|May 10, 2017
Overview of Neuropeptides: Awakening the Senses?Andrew F Russo
Pharmacogenomics|February 5, 2008
Ramping it up: RAMP1 and the implications for migraineAndrew F Russo
Annual Review of Pharmacology and Toxicology|October 24, 2014
Calcitonin gene-related peptide (CGRP): a new target for migraineAndrew F Russo
ACS Pharmacology & Translational Science|September 28, 2019
CGRP-based Migraine Therapeutics: How Might They Work, Why So Safe, and What Next?Andrew F Russo
British Journal of Clinical Pharmacology|June 3, 2015
CGRP as a neuropeptide in migraine: lessons from miceAndrew F Russo
Current Opinion in Neurology|May 13, 2009
Calcitonin gene-related peptide: an update on the biologyAna Recober, Andrew F Russo
The Journal of Headache and Pain|April 3, 2023
Shared and independent roles of CGRP and PACAP in migraine pathophysiologyAdisa Kuburas, Andrew F Russo
Idrugs : the Investigational Drugs Journal|August 1, 2007
Olcegepant, a non-peptide CGRP1 antagonist for migraine treatmentAna Recober, Andrew F Russo
Cephalalgia : an International Journal of Headache|July 11, 2018
Current understanding of trigeminal ganglion structure and function in headacheKarl Messlinger, Andrew F Russo
Pageof 10